83 related articles for article (PubMed ID: 20102207)
41. Synthesis and antitumor activity evaluations of albumin-binding prodrugs of CC-1065 analog.
Wang Y; Jiang J; Jiang X; Cai S; Han H; Li L; Tian Z; Jiang W; Zhang Z; Xiao Y; Wright SC; Larrick JW
Bioorg Med Chem; 2008 Jul; 16(13):6552-9. PubMed ID: 18508273
[TBL] [Abstract][Full Text] [Related]
42. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ
Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431
[TBL] [Abstract][Full Text] [Related]
43. CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo.
Hjarnaa PJ; Jonsson E; Latini S; Dhar S; Larsson R; Bramm E; Skov T; Binderup L
Cancer Res; 1999 Nov; 59(22):5751-7. PubMed ID: 10582695
[TBL] [Abstract][Full Text] [Related]
44. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
Pettit GR; Lippert JW
Anticancer Drug Des; 2000 Jun; 15(3):203-16. PubMed ID: 11049088
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of cinnamyl compounds as potent antitumor agents.
Shin DS; Kim J; Han DC; Son KH; Lee CW; Kim HM; Hong SH; Kwon BM
Bioorg Med Chem Lett; 2007 Oct; 17(19):5423-7. PubMed ID: 17683933
[TBL] [Abstract][Full Text] [Related]
46. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
47. Discovery of phosphoric acid mono-{2-[(E/Z)-4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-benzoylimino]-thiazol-3-ylmethyl} ester (Lu AA47070): a phosphonooxymethylene prodrug of a potent and selective hA(2A) receptor antagonist.
Sams AG; Mikkelsen GK; Larsen M; Langgård M; Howells ME; Schrøder TJ; Brennum LT; Torup L; Jørgensen EB; Bundgaard C; Kreilgård M; Bang-Andersen B
J Med Chem; 2011 Feb; 54(3):751-64. PubMed ID: 21210664
[TBL] [Abstract][Full Text] [Related]
48. Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase.
Mortlock AA; Foote KM; Heron NM; Jung FH; Pasquet G; Lohmann JJ; Warin N; Renaud F; De Savi C; Roberts NJ; Johnson T; Dousson CB; Hill GB; Perkins D; Hatter G; Wilkinson RW; Wedge SR; Heaton SP; Odedra R; Keen NJ; Crafter C; Brown E; Thompson K; Brightwell S; Khatri L; Brady MC; Kearney S; McKillop D; Rhead S; Parry T; Green S
J Med Chem; 2007 May; 50(9):2213-24. PubMed ID: 17373783
[TBL] [Abstract][Full Text] [Related]
49. Water-soluble prodrugs of an Aurora kinase inhibitor.
Oslob JD; Heumann SA; Yu CH; Allen DA; Baskaran S; Bui M; Delarosa E; Fung AD; Hashash A; Hau J; Ivy S; Jacobs JW; Lew W; Maung J; McDowell RS; Ritchie S; Romanowski MJ; Silverman JA; Yang W; Zhong M; Fuchs-Knotts T
Bioorg Med Chem Lett; 2009 Mar; 19(5):1409-12. PubMed ID: 19186057
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of pochoxime prodrugs as potent HSP90 inhibitors.
Wang C; Barluenga S; Koripelly GK; Fontaine JG; Chen R; Yu JC; Shen X; Chabala JC; Heck JV; Rubenstein A; Winssinger N
Bioorg Med Chem Lett; 2009 Jul; 19(14):3836-40. PubMed ID: 19410458
[TBL] [Abstract][Full Text] [Related]
51. Optimization of naphthalimide-imidazoacridone with potent antitumor activity leading to clinical candidate (HKH40A, RTA 502).
Hariprakasha HK; Kosakowska-Cholody T; Meyer C; Cholody WM; Stinson SF; Tarasova NI; Michejda CJ
J Med Chem; 2007 Nov; 50(23):5557-60. PubMed ID: 17939651
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and evaluation of anticancer activity of BOC26P, an ortho-aryl chalcone sodium phosphate as water-soluble prodrugs in vitro and in vivo.
Zhu C; Wang R; Zheng W; Chen D; Yue X; Cao Y; Qin W; Sun H; Wang Y; Liu Z; Li B; Du J; Bu X; Zhou B
Biomed Pharmacother; 2017 Dec; 96():551-562. PubMed ID: 29032339
[TBL] [Abstract][Full Text] [Related]
53. A novel 2'-(N-methylpyridinium acetate) prodrug of paclitaxel induces superior antitumor responses in preclinical cancer models.
Wrasidlo W; Gaedicke G; Guy RK; Renaud J; Pitsinos E; Nicolaou KC; Reisfeld RA; Lode HN
Bioconjug Chem; 2002; 13(5):1093-9. PubMed ID: 12236791
[TBL] [Abstract][Full Text] [Related]
54. [Synthesis and anticancer activity of norcantharidin-galactose derivatives].
Fan F; Sun XF
Yao Xue Xue Bao; 2008 Feb; 43(2):157-61. PubMed ID: 18507342
[TBL] [Abstract][Full Text] [Related]
55. Water soluble prodrugs of the antitumor agent 3-[(3-amino-4-methoxy)phenyl]-2-(3,4,5-trimethoxyphenyl)cyclopent-2-ene-1-one.
Nam NH; Kim Y; You YJ; Hong DH; Kim HM; Ahn BZ
Bioorg Med Chem; 2003 Mar; 11(6):1021-9. PubMed ID: 12614888
[TBL] [Abstract][Full Text] [Related]
56. Design and Characterization of a Pyridone-Containing EZH2 Inhibitor Phosphate Prodrug.
Kung PP; Fan C; Gukasyan HJ; Huang B; Kephart S; Kraus M; Lee JH; Sutton SC; Yamazaki S; Zehnder L
J Med Chem; 2021 Feb; 64(3):1725-1732. PubMed ID: 33529029
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug carboplatin designed as albumin-binding prodrugs.
Warnecke A; Fichtner I; Garmann D; Jaehde U; Kratz F
Bioconjug Chem; 2004; 15(6):1349-59. PubMed ID: 15546202
[TBL] [Abstract][Full Text] [Related]
58. The quinolone derivative CHM-1 inhibits murine WEHI-3 leukemia in BALB/c mice in vivo.
Lai TY; Yang JS; Wu PP; Huang WW; Kuo SC; Ma CY; Gibson Wood W; Chung JG
Leuk Lymphoma; 2010 Nov; 51(11):2098-102. PubMed ID: 20846096
[TBL] [Abstract][Full Text] [Related]
59. Mechanistic studies on regioselective dephosphorylation of phosphate prodrugs during a facile synthesis of antitumor phosphorylated 2-phenyl-6,7-methylenedioxy-1H-quinolin-4-one.
Cheng YY; Liu CY; Huang LJ; Huang CH; Lee KH; Lin CT; Kuo SC
Molecules; 2013 Jul; 18(7):8028-45. PubMed ID: 23884134
[TBL] [Abstract][Full Text] [Related]
60. Prodrug esters of the indolocarbazole CEP-751 (KT-6587).
Hudkins RL; Iqbal M; Park CH; Goldstein J; Herman JL; Shek E; Murakata C; Mallamo JP
Bioorg Med Chem Lett; 1998 Jul; 8(14):1873-6. PubMed ID: 9873450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
